Features of the course of COVID-19 in pregnant women

Aim. To study the features of the course of COVID-19 in pregnant women, the outcomes of a new coronavirus infection and pregnancy, the effect of concomitant pathology on the severity of the course and the frequency of complications of COVID-19.

Materials and methods. In the course of the work, a retrospective analysis of 109 medical histories of pregnant women who were treated in the infectious diseases department in 2021 with a diagnosis of COVID-19 was carried out. Anamnesis, concomitant pathology, results of objective examination, laboratory and instrumental methods of research, therapy, complications, outcomes of COVID-19 and pregnancy were evaluated.

Results. The majority of pregnant women had moderate – 55 % and severe – 24 % COVID-19, 7 % – extremely severe and only 14 % – mild. A third of pregnant women had concomitant pathology, arterial hypertension was the most common; 80 % of pregnant women had complications of COVID-19: cytokine storm – in 50 % of patients, acute respiratory distress syndrome – in 17 %, of which 5 % required artificial lung ventilation. The mortality rate was 4.6 %. The structure of pregnancy complications was dominated by gestational hypertension, gestational diabetes, premature placental abruption, preeclampsia. Complications of childbirth – premature birth and premature discharge of amniotic fluid. However, in most cases, pregnancy (75 %) and childbirth (71 %) proceeded without complications. Women in 95 % of cases were discharged from the hospital with recovery or significant clinical improvement.

Conclusion. Despite the prevalence of moderate and severe forms of COVID-19 in pregnant women, a high percentage of concomitant pathology and complications, in most cases favorable outcomes of both COVID-19 and pregnancy were noted. The presence of hypertension syndrome should probably be considered as a prognostically unfavorable marker of severe course and adverse outcomes of COVID-19 in pregnant women.

1. Poorolajal J. The global pandemics are getting more frequent and severe. J Res Health Sci 2021;21(1):е00502. DOI: 10.34172/jrhs.2021.40

2. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). ArcGIS. Johns Hopkins University. Available at: https://coronavirus.jhu.edu/map.html

3. Arutyunov G.P., Tarlovskaya E.I., Arutyunov A.G. et al. International Registry “Analysis of the dynamics of comorbid diseases in patients who have been infected with SARS-CoV-2 (ACTIVE SARS-CoV-2)”. Kardiologiya = Cardiology 2020; 60(11):30–4. (In Russ.)]. DOI: 10.15829/1560-4071-2021-4470

4. Wastnedge E., Reynolds R., van Boeckel S. еt al. Pregnancy and COVID-19. Physiol Rev 2021;101(1):303–18. DOI: 10.1152/physrev.00024.2020

5. Soma-Pillay P., Nelson-Piercy C., Tolppanen H. et al. Physiological changes in pregnancy. Cardiovasc J Afr 2016;27(2):89–94. DOI: 10.5830/CVJA-2016–021

6. Kadir R.A., Kobayashi T., Iba T. et al. COVID-19 coagulopathy in pregnancy: Critical review, preliminary recommendations, and ISTH registry – Communication from the ISTH SSC for Women’s Health. J Thromb Haemost 2020;18(11):3086–98. DOI: 10.1111/jth.15072

7. Dashraath P., Wong J.L.J., Lim M.X.K. et al. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. Am J Obstet. Gynecol 2020;222(6):521–31. DOI: 10./j.ajog.2020.03.021

8. Diriba K., Awulachew E., Getu E. The effect of coronavirus infection (SARS-CoV-2, MERS-CoV, and SARS-CoV) during pregnancy and the possibility of vertical maternal-fetal transmission: a systematic review and meta-analysis. Eur J Med Res 2020;25(1):39. DOI: 10.118/s40001-020-00439-w

9. Andreeva M.D., Karakhalis L.Yu., Penzhoyan G.A. et al. Delivery in the setting of COVID-19 infection: a clinical observation. Akusherstvo i ginekologiya: novosti, mneniya, obuchenie = Obstetrics and gynecology: news, opinions, training. 2020;8(2): 25–35. (In Russ.). DOI: 10.24411/2303-9698-2020-12001

10. Alfaraj S.H., Al-Tawfiq J.A., Memish Z.A. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection during pregnancy: Report of two cases & review of the literature. J Microbiol Immunol Infect 2019;52(3):501–3. DOI: 10.1016/j.jmii.2018.04.005

11. Liu D., Li L., Wu X. et al. Pregnancy and perinatal outcomes of women with coronavirus disease (COVID-19) pneumonia: a preliminary analysis. AJR Am J Roentgenol 2020;215(1):127–32. DOI: 10.2214/AJR.20.23072

12. Pierce-Williams R.A.M., Burd J., Felder L. et al. Clinical course of severe and critical coronavirus disease 2019 in hospitalized pregnancies: a United States cohort study. Am J Obstet Gynecol MFM 2020;2(3)

13. Sakhautdinova I.V., Tayupova I.M., Zasyadkin I.S., Gromenko R.I. Pregnancy, childbirth and perinatal outcomes in the new coronavirus infection COVID-19. Medicinskij vestnik Bashkortostana = Bashkortostan Medical Journal 2021;16(6):47–50. (In Russ.).

14. Capobianco G., Saderi L., Aliberti S. et al. COVID-19 in pregnant women: A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol 2020;252:543–58. DOI: 10.1016/j.ejogrb.2020.07.006

15. Mullins E., Evans D., Viner R.M. et al. Coronavirus in pregnancy and delivery: rapid review. Ultrasound Obstet Gynecol 2020;55(5):586–92. DOI: 10.1002/uog.22014

16. Verma S., Carter E.B., Mysorekar I.U. SARS-CoV2 and pregnancy: An invisible enemy? Am J Reprod Immunol 2020;84(5):e13308. DOI: 10.1111/aji.13308

17. Thompson J.L., Nguyen L.M., Noble K.N. et al. COVID-19-related disease severity in pregnancy. Am J Reprod Immunol 2020;84(5):e13339. DOI: 10.1111/aji.13339

18. Jafari M., Pormohammad A., Sheikh Neshin S.A. et al. Clinical characteristics and outcomes of pregnant women with COVID-19 and comparison with control patients: A systematic review and meta-analysis. Rev Med Virol 2021;31(5):1–16. DOI: 10.1002/rmv.2208

19. Vukolova V.A., Enkova E.V., Ryzhikov Yu.S. Evaluation of the course of pregnancy, childbirth and the condition of the fetus in women with COVID-19. Vestnik novy`x medicinskix texnologij = Bulletin of new medical technologies. 2020;6:56–62. (In Russ.). DOI: 10.24411/2075-4094-2020-16778

20. Schwartz D.A. An analysis of 38 pregnant women with COVID-19, their newborn infants, and maternal-fetal transmission of SARS-CoV-2: maternal coronavirus infections and pregnancy outcomes. Arch Pathol Lab Med 2020;144(7):799–805. DOI: 10.5858/arpa.2020-0901-SA

21. Temporary guidelines "Prevention, diagnosis and treatment of new coronavirus infections". Version 10 (08.02.2021). The Ministry of Health of Russia. Available at: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/054/662/original/Временные_МР_COVID-19_%28v.10%29.pdf

22. Verbic M.D., Gruban J., Kos M.K. Incidence and control of steroid-induced hyperglycaemia in hospitalised patients at a tertiary care centre for lung diseases. Pharmacol Reports 2021;73(3):796–805. DOI: 10.1007/s43440-021-00234-2

23. Hamdy O., Gabbay R.A. Early observation and mitigation of challenges in diabetes management of COVID-19 patients in critical care units. Diabetes Care 2020;43(8):e81–2. DOI: 10.2337/dc20-0944

24. Adamyan R.V., Vecherko V.I., Konysheva O.V., Harchenko E.I. Pregnancy and COVID-19: current issues (literature review). Problemy reprodukcii = Reproduction problems 2021;27(3):70–7 (In Russ). DOI: 10.17116/repro20212703170

25. Baranovskaya E.I. Maternal mortality in the modern world. Akusherstvo, Ginekologiya i Reprodukciya = Obstetrics, gynecology and reproduction 2022;16(3):296–305. (In Russ). DOI: 10.17749/2313-7347/ob.gyn.rep.2022.279